ID20717A - Proses yang diperbaiki untuk memperoleh prekursor-prekursor insulin yang mempunyai jembatan-jembatan sistin yang terikat dengan tepat - Google Patents

Proses yang diperbaiki untuk memperoleh prekursor-prekursor insulin yang mempunyai jembatan-jembatan sistin yang terikat dengan tepat

Info

Publication number
ID20717A
ID20717A IDP981136A ID981136A ID20717A ID 20717 A ID20717 A ID 20717A ID P981136 A IDP981136 A ID P981136A ID 981136 A ID981136 A ID 981136A ID 20717 A ID20717 A ID 20717A
Authority
ID
Indonesia
Prior art keywords
improved process
right bridge
insulin precursors
bridge systems
obtain insulin
Prior art date
Application number
IDP981136A
Other languages
English (en)
Inventor
Franz-Josef Rubroder
Reinhold Keller
Original Assignee
Hoechst Marion Roussel De Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Marion Roussel De Gmbh filed Critical Hoechst Marion Roussel De Gmbh
Publication of ID20717A publication Critical patent/ID20717A/id

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/12—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by hydrolysis, i.e. solvolysis in general
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/62—Insulins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
    • A61P5/50—Drugs for disorders of the endocrine system of the pancreatic hormones for increasing or potentiating the activity of insulin
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/02—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length in solution
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Diabetes (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Endocrinology (AREA)
  • Analytical Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Emergency Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
IDP981136A 1997-08-18 1998-08-14 Proses yang diperbaiki untuk memperoleh prekursor-prekursor insulin yang mempunyai jembatan-jembatan sistin yang terikat dengan tepat ID20717A (id)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19735711A DE19735711C2 (de) 1997-08-18 1997-08-18 Verfahren zur Herstellung eines Vorläufers von Insulin oder Insulinderivaten mit korrekt verbundenen Cystinbrücken

Publications (1)

Publication Number Publication Date
ID20717A true ID20717A (id) 1999-02-18

Family

ID=7839275

Family Applications (1)

Application Number Title Priority Date Filing Date
IDP981136A ID20717A (id) 1997-08-18 1998-08-14 Proses yang diperbaiki untuk memperoleh prekursor-prekursor insulin yang mempunyai jembatan-jembatan sistin yang terikat dengan tepat

Country Status (20)

Country Link
US (3) US5986048A (id)
EP (2) EP0906918B1 (id)
JP (1) JP4291900B2 (id)
KR (2) KR100537842B1 (id)
CN (3) CN101186940B (id)
AR (1) AR016821A1 (id)
AT (2) ATE217636T1 (id)
AU (1) AU744824B2 (id)
BR (2) BRPI9816233B8 (id)
CA (1) CA2245151C (id)
CZ (1) CZ295679B6 (id)
DE (3) DE19735711C2 (id)
DK (2) DK0906918T3 (id)
ES (2) ES2177178T3 (id)
HU (2) HU228161B1 (id)
ID (1) ID20717A (id)
PL (1) PL191901B1 (id)
PT (2) PT906918E (id)
RU (2) RU2205836C2 (id)
TR (1) TR199801587A3 (id)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19735711C2 (de) * 1997-08-18 2001-04-26 Aventis Pharma Gmbh Verfahren zur Herstellung eines Vorläufers von Insulin oder Insulinderivaten mit korrekt verbundenen Cystinbrücken
DE19930676B4 (de) 1999-07-02 2006-01-19 Sanofi-Aventis Deutschland Gmbh Verfahren zur Stabilisierung von Insulin, Insulinderivaten und/oder deren Vorläufer in komplexen Mischungen bei deren Lagerung in wäßrigen Lösungsmitteln
WO2001046453A1 (en) 1999-12-22 2001-06-28 Novo Nordisk A/S Method for extractive refolding of scrambled single-chain polypeptides
EP1303532A2 (en) * 2000-07-12 2003-04-23 Eli Lilly And Company Process to increase protein stability
DE10235168A1 (de) * 2002-08-01 2004-02-12 Aventis Pharma Deutschland Gmbh Verfahren zur Reinigung von Preproinsulin
DE102004015965A1 (de) * 2004-04-01 2005-10-20 Aventis Pharma Gmbh Verfahren zur Gewinnung von Insulinen durch verbesserte Luftbegasung der Faltung
NZ568809A (en) 2005-12-22 2011-08-26 Genentech Inc Recovering and purification of VEGF proteins from prokaryotic cells using polyanionic agents
AU2007272412B2 (en) * 2006-07-14 2013-11-07 Genentech, Inc. Refolding of recombinant proteins
EA018715B1 (ru) * 2007-07-03 2013-10-30 Эмджен Инк. Количественное определение белков с использованием сухого веса внутриклеточных телец
RU2451750C2 (ru) * 2007-09-24 2012-05-27 Общество С Ограниченной Ответственностью "Герофарм" Способ получения рекомбинантного с-пептида проинсулина человека
PL2229407T3 (pl) 2008-01-09 2017-06-30 Sanofi-Aventis Deutschland Gmbh Nowe pochodne insuliny o ekstremalnie spowolnionym profilu czasu działania
CA2724510C (en) * 2008-04-30 2015-10-27 Wockhardt Research Centre Processes for refolding of insulin
EP3228320B1 (de) 2008-10-17 2019-12-18 Sanofi-Aventis Deutschland GmbH Kombination von einem insulin und einem glp-1-agonisten
PT2554183T (pt) 2009-11-13 2018-07-09 Sanofi Aventis Deutschland Composição farmacêutica que compreende um agonista de glp-1, uma insulina e metionina
PE20121316A1 (es) 2009-11-13 2012-10-05 Sanofi Aventis Deutschland Composicion farmaceutica que comprende un agonista de glp-1 y metionina
US20140148384A1 (en) 2010-08-30 2014-05-29 Sanofi-Aventis Deutschland Gmbh Use of ave0010 for the manufacture of a medicament for the treatment of diabetes mellitus type 2
US9821032B2 (en) 2011-05-13 2017-11-21 Sanofi-Aventis Deutschland Gmbh Pharmaceutical combination for improving glycemic control as add-on therapy to basal insulin
TWI559929B (en) 2011-09-01 2016-12-01 Sanofi Aventis Deutschland Pharmaceutical composition for use in the treatment of a neurodegenerative disease
US12157766B2 (en) * 2012-08-05 2024-12-03 Absci Corporation Cytoplasmic expression system
WO2014099577A1 (en) 2012-12-17 2014-06-26 Merck Sharp & Dohme Corp. Process for purifying insulin and analogues thereof
PE20151409A1 (es) * 2013-02-26 2015-10-07 Hanmi Pharm Ind Co Ltd Analogo de insulina novedoso y su uso
CN103694339B (zh) * 2013-12-04 2017-10-13 珠海联邦制药股份有限公司 一种甘精胰岛素前体的复性方法
US10407483B2 (en) 2014-03-14 2019-09-10 Merck Sharp & Dohme Corp. Purifying insulin using cation exchange and reverse phase chromatography in the presence of an organic modifier and elevated temperature
TWI758239B (zh) 2014-12-12 2022-03-21 德商賽諾菲阿凡提斯德意志有限公司 甘精胰島素/利司那肽固定比率配製劑
TWI748945B (zh) 2015-03-13 2021-12-11 德商賽諾菲阿凡提斯德意志有限公司 第２型糖尿病病患治療
TW201705975A (zh) 2015-03-18 2017-02-16 賽諾菲阿凡提斯德意志有限公司 第２型糖尿病病患之治療
CN104911203A (zh) * 2015-06-30 2015-09-16 成都易胜科生物科技有限公司 一种重组人胰岛素的工业制备方法
EP3344651B1 (en) 2015-09-02 2022-03-02 Merck Sharp & Dohme Corp. A process for obtaining insulin with correctly formed disulfide bonds
WO2017205309A1 (en) * 2016-05-25 2017-11-30 Merck Sharp & Dohme Corp. Insulin receptor partial agonists
WO2018018613A1 (zh) 2016-07-29 2018-02-01 广东东阳光药业有限公司 一种提高抗体纯度的细胞培养基和培养方法
CN113773391B (zh) * 2020-06-09 2023-10-20 宁波鲲鹏生物科技有限公司 一种门冬胰岛素的制备方法
CN113773400B (zh) * 2020-06-09 2023-08-18 宁波鲲鹏生物科技有限公司 一种门冬胰岛素衍生物及其应用
CN113773396A (zh) * 2020-06-10 2021-12-10 宁波鲲鹏生物科技有限公司 一种地特胰岛素衍生物及其应用
JP7749397B2 (ja) * 2021-09-30 2025-10-06 キヤノン株式会社 超音波ファントム及び超音波ファントムの製造方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ199391A (en) * 1981-01-02 1985-12-13 Genentech Inc Chimeric polypeptides comprising a proinsulin sequence,and preparation by recombinant dna technique;production of human insulin
DE3501641A1 (de) * 1985-01-19 1986-07-24 Hoechst Ag, 6230 Frankfurt Verfahren zur gewinnung von insulin-vorlaeufern aus reaktionsgemischen, die bei der faltung von insulin-vorlaeufern aus den entsprechenden s-sulfonaten anfallen
GR1005153B (el) * 1989-08-29 2006-03-13 The General Hospital Corporation Πρωτεινες συντηξεως, παρασκευη τους και χρηση τους.
RU2045535C1 (ru) * 1991-06-18 1995-10-10 Институт биоорганической химии им.М.М.Шемякина и Ю.А.Овчинникова РАН Способ получения проинсулина человека
EP0600372B1 (de) * 1992-12-02 1997-02-05 Hoechst Aktiengesellschaft Verfahren zur Gewinnung von Proinsulin mit korrekt verbundenen Cystinbrücken
DE4405179A1 (de) * 1994-02-18 1995-08-24 Hoechst Ag Verfahren zur Gewinnung von Insulin mit korrekt verbundenen Cystinbrücken
RU2081122C1 (ru) * 1994-06-16 1997-06-10 Институт биоорганической химии им.М.М.Шемякина и Ю.А.Овчинникова РАН Способ выделения и очистки инсулина или его биотехнологических предшественников
NZ279002A (en) * 1994-12-29 1999-02-25 Bio Technology General Corp Production of recombinant human insulin by folding a proinsulin hybrid polypeptide obtained from a bacterial cell
DE19735711C2 (de) 1997-08-18 2001-04-26 Aventis Pharma Gmbh Verfahren zur Herstellung eines Vorläufers von Insulin oder Insulinderivaten mit korrekt verbundenen Cystinbrücken

Also Published As

Publication number Publication date
ATE217636T1 (de) 2002-06-15
ES2176870T3 (es) 2002-12-01
DE59803985D1 (de) 2002-06-06
BRPI9816233B1 (pt) 2016-09-27
JPH11130798A (ja) 1999-05-18
CZ259898A3 (cs) 1999-03-17
EP0906918A2 (de) 1999-04-07
DE19735711C2 (de) 2001-04-26
EP0980874A1 (de) 2000-02-23
PL191901B1 (pl) 2006-07-31
CA2245151A1 (en) 1999-02-18
CN101186940B (zh) 2012-02-08
TR199801587A2 (xx) 1999-03-22
DK0980874T3 (da) 2002-08-19
EP0906918A3 (de) 1999-08-11
CN1209437A (zh) 1999-03-03
US6380355B1 (en) 2002-04-30
KR19990023651A (ko) 1999-03-25
PT906918E (pt) 2002-10-31
US6727346B2 (en) 2004-04-27
CZ295679B6 (cs) 2005-09-14
HK1061870A1 (en) 2004-10-08
DE59804121D1 (de) 2002-06-20
CA2245151C (en) 2009-10-06
HU228161B1 (en) 2013-01-28
EP0980874B1 (de) 2002-05-02
KR100574580B1 (ko) 2006-04-28
US5986048A (en) 1999-11-16
CN1483831A (zh) 2004-03-24
CN101186940A (zh) 2008-05-28
PT980874E (pt) 2002-10-31
KR100537842B1 (ko) 2006-03-23
HK1119449A1 (en) 2009-03-06
TR199801587A3 (tr) 1999-03-22
DE19735711A1 (de) 1999-02-25
BR9803755A (pt) 2000-03-28
ES2177178T3 (es) 2002-12-01
ATE217012T1 (de) 2002-05-15
RU2205836C2 (ru) 2003-06-10
JP4291900B2 (ja) 2009-07-08
HU0600287D0 (en) 2006-05-29
US20020156234A1 (en) 2002-10-24
HU9801886D0 (en) 1998-10-28
DK0906918T3 (da) 2002-09-09
CN1132845C (zh) 2003-12-31
HUP9801886A2 (hu) 1999-01-28
AR016821A1 (es) 2001-08-01
EP0906918B1 (de) 2002-05-15
PL328108A1 (en) 1999-03-01
HUP9801886A3 (en) 1999-06-28
KR20050067371A (ko) 2005-07-01
BRPI9816233B8 (pt) 2021-05-25
HK1018464A1 (en) 1999-12-24
RU2302882C2 (ru) 2007-07-20
CN1483831B (zh) 2012-06-13
AU8076398A (en) 1999-02-25
HU228203B1 (en) 2013-01-28
AU744824B2 (en) 2002-03-07

Similar Documents

Publication Publication Date Title
ID20717A (id) Proses yang diperbaiki untuk memperoleh prekursor-prekursor insulin yang mempunyai jembatan-jembatan sistin yang terikat dengan tepat
ID24323A (id) Proses hidrosianasi yang tertingkatkan
ID21268A (id) Proses yang ditingkatkan untuk membuat akrilonitril atau metakrilonitril dari propana atau isobutana dengan amoksidasi
ID27884A (id) Asam-asam indolealkanoat yang disubstitusikan.
DE69801659D1 (de) Kodierungssysteme
DE59807316D1 (de) Endoskopisches system
ID29207A (id) Komposisi katalitis yang sesuai untuk proses fischer-tropsch
DE69824042D1 (de) Filteranlage
DE69942436D1 (de) Verbessertes System zur intraluminalen Bildgebung
PT884053E (pt) Formulacoes de insulina estaveis
DE69816858D1 (de) Beatmungssystem
ID19875A (id) Poliolefin yang dimodifikasi menurut reologi
ID28110A (id) Surfaktan alkilbenzenasulfonat yang disempurnakan
DE69833445D1 (de) Verbindersystem
DE69824631D1 (de) Filteranlage
DE69824630D1 (de) Filteranlage
ID24600A (id) Proses pembuatan poliol-poliol polieter dan poliol yang dibuat bersamaan
ID24596A (id) Mikrosfer-mikrosfer farmasi yang mengandung asam valproat untuk pemakaian oral
ID22572A (id) Proses yang disempurnakan untuk pembuatan 3,5,5-trimetilsikloheksa-3-en-1-on (betha-isoforon) dengan isomerisasi 3,5,5-trimetilsikloheksa-2-en-1-on (alpha-isoforon) (ii)
DE69829075D1 (de) Filteranlage
ID22662A (id) Proses pemurnian kaprolaktam
ID16154A (id) Komposisi monomer yang distabilisasi
DE69915738D1 (de) Positiv verriegelter Steckverbinder
DE69803818D1 (de) Verbinderverriegelung
DK0973769T3 (da) Fremgangsmåde til fremstilling af eprosartan